Castañares, Flordeliza P.

HRN: 27-34-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2025
CEFUROXIME 1.5GM (VIAL)
08/23/2025
08/24/2025
IV
1.5gms
PTOR
For Elective CS
Checking Initial Appropriateness 
08/23/2025
CEFUROXIME 1.5GM (VIAL)
08/23/2025
08/24/2025
IV
1.5g
Q8 X 2hrs
S/p Lstcs
Checking Initial Appropriateness 
08/23/2025
CEFUROXIME 500MG (TAB)
08/23/2025
08/29/2025
PO
500mg
BID X 7 Days
S/p Lstcs
Checking Initial Appropriateness 
08/23/2025
MUPIROCIN 2%, 15G (TUBE)
08/23/2025
08/29/2025
TOPICAL
Pea Size
Once A Day
S/p Lscts
Checking Initial Appropriateness 
08/23/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/23/2025
08/24/2025
IV
500mg
Q8 X 3 Doses
S/p Lstcs
Checking Initial Appropriateness 
08/23/2025
METRONIDAZOLE 500MG (TAB)
08/23/2025
08/29/2025
PO
500mg
1 Tab TID X 7 Days
S/p Lscts
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: